Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$339,439,917
+$55,693,632 QoQ
Shares Held
283,001
-8.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#195
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$8,450,904
PutShares
23,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $812,352,405 across 9 Drug Manufacturers - General names. LLY ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
283,001 | $339,439,917 | |
| 2 | JNJ |
Johnson & Johnson
|
647,222 | $164,374,971 | |
| 3 | ABBV |
AbbVie Inc.
|
399,893 | $100,629,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
650,503 | $83,589,635 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
356,488 | $45,038,693 | |
| 6 | PFE |
Pfizer Inc
|
1,753,548 | $42,225,435 | |
| 7 | AMGN |
Amgen Inc
|
68,480 | $24,797,977 | |
| 8 | BIIB |
Biogen Inc.
|
34,879 | $7,535,956 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,439,917 | 283,001 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $283,746,285 | 308,497 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $292,908,359 | 272,554 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $209,300,819 | 274,313 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $217,152,113 | 278,568 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $225,560,976 | 273,106 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $225,405,472 | 291,976 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $255,631,785 | 288,543 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $300,044,742 | 331,402 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $262,743,542 | 337,734 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $217,921,144 | 373,844 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $202,356,207 | 376,736 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $181,427,257 | 386,855 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $142,506,250 | 414,962 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $164,245,697 | 448,955 | Shares | Sole | 2023-01-26 | |
| 2022-12-31 | $8,450,904 | 23,100 | Put | Sole | 2023-01-26 | |
| 2022-09-30 | $162,616,595 | 502,912 | Shares | Sole | 2022-10-24 | |
| 2022-09-30 | $8,439,435 | 26,100 | Put | Sole | 2022-10-24 | |
| 2022-06-30 | $160,987,976 | 496,524 | Shares | Sole | 2022-08-01 | |
| 2022-06-30 | $8,462,403 | 26,100 | Put | Sole | 2022-08-01 | |
| 2022-03-31 | $143,318,162 | 500,465 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $134,349,817 | 486,387 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $105,900,843 | 458,346 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $107,029,307 | 466,318 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $74,462,528 | 398,579 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $57,803,724 | 342,358 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $53,283,499 | 359,975 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $56,124,933 | 341,850 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $35,182,582 | 253,623 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||